Core Insights - The rapid rise of China's cutting-edge biotechnology industry is driving significant opportunities for the automated low-temperature storage sector, which is crucial for life sciences research [1][3] Company Overview - Yuaneng Biological, established in 2017, focuses on the R&D, product design, and manufacturing of advanced biomedical equipment, particularly automated and intelligent low-temperature storage devices [3] - The company has developed a series of intelligent biological sample storage products with independent intellectual property rights, having filed over 600 patents and received more than 500 authorizations as of December 2024 [3] - Yuaneng Biological leads the domestic market in automated biological sample storage and has exported products to regions including the EU, the US, and Japan [3] Market Potential - The Chinese low-temperature storage market is projected to grow from a market size of 6.77 billion yuan in 2022 to 19.25 billion yuan by 2027, with a compound annual growth rate (CAGR) of 23.24% [4] - The increasing investment in R&D by domestic innovative pharmaceutical companies and the expanding biopharmaceutical market, along with an improving cold chain regulatory system, are creating a strong demand foundation for the low-temperature storage market [3][4] Investment and Financing - Yuaneng Biological has demonstrated strong financing capabilities, having completed a Series A financing round of 410 million yuan and is now initiating a Series B round, with plans to list on the Sci-Tech Innovation Board [3]